Method of monitoring a disease caused by genomic translocation

The present invention relates to methods of monitoring, diagnosing and gaining insights into the status and prognosis of, in particular, chronic myeloid leukaemia patients based on, for example quantitative analysis of genomic DNA of leukemic cells. It also extends to methods of treatment based on the results of the method.